Medtronic plc
MDTNYSEHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $122.61B
- P/E (TTM)
- 23.44
- Forward P/E
- 21.19
- Dividend yield
- 2.96%
- 52-week range
- $73.31$106.33
- Volume (live)
- -
- Avg. volume (3M)
- 25.05M
Medtronic (MDT) Stock Price & Financial Analysis
Medtronic Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $95.38 - $96.89 |
|---|---|
| 52-Week High | $106.33 |
| 52-Week Low | $73.31 |
| Open | $96.10 |
| Volume (last close) | 6.01M |
| Average Volume (3M) | 25.05M |
| Revenue (TTM) | 37.54B |
|---|---|
| Net Income (TTM) | 5.23B |
| Free Cash Flow (TTM) | 6.13B |
| EPS (TTM) | $4.06 |
| Profit Margin | 13.93% |
| Operating Margin | 18.11% |
| Return on Equity (ROE) | 10.41% |
| Debt to Equity | 0.56 |
| Annual Dividend | $2.86 |
|---|---|
| Dividend Yield | 2.96% |
| Payout Ratio | 70.40% |
| Last Dividend Ex-Date | Sep 25, 2026 |
| Market Cap | 122.61B |
|---|---|
| Shares Outstanding | 1.29B |
| P/E Ratio (TTM) | 23.44 |
| Forward P/E | 21.19 |
| Price to Sales (P/S) | 3.27 |
| Price to Book (P/B) | 2.44 |
| EV/EBITDA | 15.67 |
| 50-Day MA | $91.11 |
|---|---|
| 200-Day MA | $88.28 |
| 1-Year Change | +2.53% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Medtronic at a Glance
As of the Oct 23, 2026 close, Medtronic (MDT) has a market capitalization of $122.61B. The stock trades at 23.4× trailing earnings, 21.2× forward earnings and 3.3× sales. Over the trailing twelve months it earned $5.23B on revenue of $37.54B (a 13.9% profit margin) and generated $6.13B of free cash flow. Revenue grew 9.8% year over year.
As of its latest reported balance sheet, it holds $1.79B in cash and securities against $28.20B of debt, a net debt position of $26.41B.
Medtronic pays a quarterly dividend totaling $2.86 per share a year, a 2.96% yield at the Oct 23, 2026 close, with a 70% payout ratio and 43 consecutive years of dividend increases.
The share price is up 2.5% over the past year. At $95.41 (the Oct 23, 2026 close) it sits within its 52-week range of $73.31 to $106.33, above its 200-day moving average of $88.28.
Based on 25 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $102.73, 7.7% above the Oct 23, 2026 close.
Frequently Asked Questions About Medtronic
What is the current stock price for MDT?
As of the Oct 23, 2026 close, MDT stock trades at $95.41. The 52-week range is $73.31–$106.33, with a day range of $95.38–$96.89.
What is the P/E ratio for MDT?
As of the Oct 23, 2026 close, Medtronic's trailing twelve-month (TTM) P/E ratio is 23.4, meaning investors pay $23.4 for every $1 of annual earnings. The forward P/E is 21.2, reflecting analyst expectations for future earnings. Medtronic operates in the Healthcare sector.
Does MDT pay dividends?
Yes, Medtronic pays a 2.96% annual dividend yield as of the Oct 23, 2026 close ($2.86 per share a year). The trailing twelve-month payout ratio is 70.4%. The most recent ex-dividend date was September 25, 2026.
What do analysts recommend for MDT?
Based on ratings from 25 professional analysts over the last 90 days, the consensus for MDT is Buy. The average 12-month price target is $102.73, a 7.7% upside from the Oct 23, 2026 close of $95.41.
What is the market cap of MDT?
As of the Oct 23, 2026 close, Medtronic's market capitalization is $122.61B, classifying it as a large-cap company. Medtronic operates in the Healthcare sector within the Medical Devices industry.